A milestone in personalized medicine has been achieved, thanks to a substantial grant awarded to HQS Quantum Simulations by the European Innovation Council Transition Program. The €2.5 million funding will enable the development of a cutting-edge tool for high-precision structure identification using Nuclear Magnetic Resonance (NMR) spectroscopy. This innovative technology has the potential to transform the analysis of complex molecular structures and biological mixtures, paving the way for more accurate diagnostics and treatments in personalized medicine.
The European Innovation Council (EIC) has awarded a grant of €2.5 million to HQS Quantum Simulations, a leading quantum simulation company, as part of the EIC Transition Program. This funding will enable the development of a cutting-edge tool for high-precision structure identification using Nuclear Magnetic Resonance (NMR) spectroscopy.
NMR spectroscopy is a powerful analytical technique widely used in various fields, including pharmaceuticals and chemical industries. However, its application in personalized medicine has been limited due to the complexity of analyzing large biological samples. HQS Quantum Simulations aims to address this challenge by developing innovative quantum algorithms for NMR spectrum analysis.
The company’s unique approach involves creating a prototype for NMR spectrum analysis that can run on conventional computer hardware, offering added value over currently available software without the need for a quantum computer. This prototype has already shown promising results and will be further developed as part of the HQS-NextNMR project.
Quantum computing has emerged as a key technology
Quantum computing has emerged as a key technology for accelerating NMR spectrum analysis. By harnessing the power of quantum mechanics, HQS Quantum Simulations can develop more accurate and efficient algorithms for analyzing complex molecular structures and biological mixtures. This will enable the analysis of large biological samples with unprecedented precision.
The company’s involvement in the FET Open project AVaQus has provided valuable insights into the use cases for quantum computing in NMR spectroscopy. As part of this project, HQS Quantum Simulations has created unique quantum algorithms that address the challenges of NMR spectrum analysis.
The HQS-NextNMR project aims to further develop NMR spectroscopy for use in personalized medicine, with a focus on analyzing biological samples. This will enable the efficient modernization of diagnostics and open up new avenues for research in this field.
In addition, the company plans to expand the range of applications of benchtop NMR devices by developing a prototype for low-field magnetic resonance analysis. This will provide added value over currently available software without the need for a quantum computer.
The development of NMR spectroscopy as a key technology for personalized medicine has far-reaching implications. By enabling the accurate and efficient analysis of large biological samples, HQS Quantum Simulations is poised to revolutionize diagnostics and treatment strategies in this field.
As part of the EIC Transition Program, HQS
As part of the EIC Transition Program, HQS Quantum Simulations joins a community of innovative teams working on cutting-edge technologies that have the potential to transform industries and improve lives. With its unique approach to NMR spectroscopy and quantum computing, the company is well-positioned to make a significant impact in the years to come.
The funding awarded to HQS Quantum Simulations by the EIC Transition Program marks an important milestone in the development of NMR spectroscopy as a key technology for personalized medicine. By harnessing the power of quantum mechanics and innovative algorithms, the company is poised to revolutionize diagnostics and treatment strategies in this field.
As the field continues to evolve, it will be exciting to see how HQS Quantum Simulations and other innovators shape the future of NMR spectroscopy and its applications in personalized medicine.
External Link: Click Here For More
